Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Lisa Pipperger"'
Publikováno v:
Vaccines, Vol 12, Iss 8, p 867 (2024)
Numerous factors influence the magnitude and effector phenotype of vaccine-induced CD8+ T cells, thereby potentially impacting treatment efficacy. Here, we investigate the effect of vaccination dose, route of immunization, presence of a target antige
Externí odkaz:
https://doaj.org/article/26b45fe198a34fc78933cba24f6f2404
Autor:
Saskia V. Vijver, Sarah Danklmaier, Lisa Pipperger, Raphael Gronauer, Gabriel Floriani, Hubert Hackl, Krishna Das, Guido Wollmann
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Oncolytic viruses are currently tested as a novel platform for cancer therapy. These viruses preferentially replicate in and kill malignant cells. Due to their microbial origin, treatment with oncolytic viruses naturally results in anti-viral respons
Externí odkaz:
https://doaj.org/article/3b96f4f2fe924248b1bdfa54a200326f
Autor:
Hye Kyung Lee, Ludwig Knabl, Lisa Pipperger, Andre Volland, Priscilla A. Furth, Keunsoo Kang, Harold E. Smith, Romuald Bellmann, Christina Bernhard, Norbert Kaiser, Hannes Gänzer, Mathias Ströhle, Andreas Walser, Dorothee von Laer, Lothar Hennighausen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract SARS-CoV-2 infection ranges from asymptomatic to severe with lingering symptomatology in some. This prompted investigation of whether or not asymptomatic disease results in measurable immune activation post-infection. Immune activation follo
Externí odkaz:
https://doaj.org/article/210d5784963444e28175c13a1924d367
Autor:
Wegene Borena, Zoltán Bánki, Katie Bates, Hannes Winner, Lydia Riepler, Annika Rössler, Lisa Pipperger, Igor Theurl, Barbara Falkensammer, Hanno Ulmer, Andreas Walser, Daniel Pichler, Matthias Baumgartner, Sebastian Schönherr, Lukas Forer, Ludwig Knabl, Reinhard Würzner, Dorothee von Laer, Jörg Paetzold, Janine Kimpel
Publikováno v:
EBioMedicine, Vol 70, Iss , Pp 103534- (2021)
Background In early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria triggered the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a previous study, we found that the seroprevalence in the adult population of Isch
Externí odkaz:
https://doaj.org/article/cfb1fc1f676d480485676db9402ba1e4
Autor:
Lisa Pipperger, Lydia Riepler, Janine Kimpel, Anita Siller, Patrizia Stoitzner, Zoltán Bánki, Dorothee von Laer
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncolytic viruses (OVs) can eradicate tumor cells and elicit antitumor immunity. VSV-GP, a chimeric vesicular stomatitis virus (VSV) with the glycoprotein (GP) of the lymphocytic choriomeningitis virus, is a promising new OV candidate. However, the i
Externí odkaz:
https://doaj.org/article/82fd02b7598445fa861025ab33611140
Autor:
Daniel Pichler, Annika Rössler, Andreas Walser, Janine Kimpel, Igor Theurl, Jörg Paetzold, Hanno Ulmer, Dorothee von Laer, Lukas Forer, Reinhard Würzner, Zoltán Bánki, Barbara Falkensammer, Hannes Winner, Katie Bates, Lisa Pipperger, Matthias Baumgartner, Lydia Riepler, Wegene Borena, Sebastian Schönherr, Ludwig Knabl
Publikováno v:
EBioMedicine, Vol 70, Iss, Pp 103534-(2021)
EBioMedicine
EBioMedicine
Background In early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria triggered the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a previous study, we found that the seroprevalence in the adult population of Isch
Autor:
Zoltán Bánki, Anita Siller, Janine Kimpel, Lisa Pipperger, Dorothee von Laer, Lydia Riepler, Patrizia Stoitzner
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
Oncolytic viruses (OVs) can eradicate tumor cells and elicit antitumor immunity. VSV-GP, a chimeric vesicular stomatitis virus (VSV) with the glycoprotein (GP) of the lymphocytic choriomeningitis virus, is a promising new OV candidate. However, the i
Autor:
Barbara Falkensammer, Michael Meyer-Hermann, Sebastian Binder, Janine Kimpel, Mrinalini Ranjan, Wegene Borena, Lydia Riepler, Katie Bates, Lisa Pipperger, Tanmay Mitra, Ludwig Knabl, Arnab Bandyopadhyay, Dorothee von Laer, André Volland, Annika Rössler, Andreas Walser, Hanno Ulmer, Marta Schips
Publikováno v:
Communications Medicine
Communications medicine
England
Communications medicine
England
Background In early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria initiated the spread of SARS-CoV-2 throughout Austria and Northern Europe. Methods Between April 21st and 27th 2020, a cross-sectional epidemiologic study targe
Autor:
Hye Kyung Lee, Ludwig Knabl, Lisa Pipperger, Andre Volland, Priscilla Furth, Keunsoo Kang, Harold Smith, Romuald Bellmann, Christina Bernhard, Norbert Kaiser, Hannes Gänzer, Mathias Ströhle, Andreas Walser, Dorothee Von Laer, Lothar Hennighausen
Publikováno v:
Research Square
article-version (status) pre
article-version (number) 1
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
medRxiv
article-version (status) pre
article-version (number) 1
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
medRxiv
SARS-CoV-2 infection ranges from asymptomatic to severe with lingering symptomatology in some. This prompted investigation of whether or not asymptomatic disease results in measurable immune activation post-infection. Immune activation following asym
Autor:
Marta Schips, Lydia Riepler, Barbara Falkensammer, Mrinalini Ranjan, Michael Meyer-Hermann, Ludwig Knabl, Hanno Ulmer, Janine Kimpel, Sebastian Binder, Arnab Bandyopadhyay, Tanmay Mitra, André Volland, Annika Rössler, Andreas Walser, Katie Bates, Lisa Pipperger, Dorothee von Laer, Wegene Borena
BackgroundEarly March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria initiated the spread of SARS-CoV-2 throughout Austria and Northern Europe.MethodsBetween April 21 and 27, a cross-sectional epidemiologic study targeting the full p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b1f13ae976b3c2f6184370bb5a55c5